Skip to main content
Caplight Logo









Cardiosense

Cardiosense

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://cardiosense.com/

Last Round

Series B

Aug 24, 2026

Total Funding Raised

$17.7M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Cardiosense is a digital health company that develops a physiological waveform AI platform and multi-sensor devices to enable early detection and management of cardiovascular disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Healthcare Analytics, Medical AI

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

remote patient monitoringRPMwearable sensorheart failure managementcardiovascular monitoringdigital healthclinical analyticsmedical AIpredictive analyticshemodynamic monitoringhospital readmission reductionnoninvasive diagnosticswearable techSaaS analyticshealth IoTclinical decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cardiosense Comparables

Compare Cardiosense with similar companies based on industry and business-model similarity.

Cardiosense comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nanowear
85%
BioIntelliSense
82%
Bodyport
81%

Cardiosense Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 24, 2026
VC RoundApr 1, 2026
Series ADec 8, 2022
SeedJun 1, 2020

Key People

Founding team and executive leadership

Omer Inan

Chief Scientific Officer, Co-Founder, And Board Member

Founding Team

Eric Meizlish

Chief Executive Officer

Executive Team

Ehud Gelblum

Chief Financial Officer

Executive Team

Cardiosense Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 24, 2026

    $26M round completed.

  • Aug 17, 2026

    Open roles increased to 50, 2.1x the trailing average.

Cardiosense Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cardiosense Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cardiosense's valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range28
Year Founded2020
Last FundingAug 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?